A Randomized Phase II Clinical Trial of Nab-Paclitaxel and Carboplatin Compared With Gemcitabine and Carboplatin as First-line Therapy in Advanced Squamous Cell Carcinoma of Lung
Phase of Trial: Phase II
Latest Information Update: 30 Sep 2014
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin; Gemcitabine
- Indications Lung cancer
- Focus Therapeutic Use
- 04 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 30 May 2014 Primary endpoint 'objective response rate' not met.
- 30 May 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.